WS #17008
Earnings results highlight the market's punishing stance on forward guidance. Moderna rallied significantly after beating Q3 estimates and raising its full-year revenue growth outlook to 15-25%, demonstrating strong demand for its vaccines. In contrast, Charter Communications reported a massive GAAP EPS miss, and Qualcomm’s shares fell roughly 7% despite a Q4 beat due to disappointing December guidance. Tesla faces structural headwinds as it reportedly winds down Cybertruck production to focus on the Cybercab, amid persistently weak sales.
Corporate Earnings Divergence
Earnings results highlight the market's punishing stance on forward guidance. Moderna rallied significantly after beating Q3 estimates and raising its full-year revenue growth outlook to 15-25%, demonstrating strong demand for its vaccines. In contrast, Charter Communications reported a massive GAAP EPS miss, and Qualcomm’s shares fell roughly 7% despite a Q4 beat due to disappointing December guidance. Tesla faces structural headwinds as it reportedly winds down Cybertruck production to focus on the Cybercab, amid persistently weak sales.